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Isolation and Characterization of the Herpes Simplex Virus 1
Terminase Complex
Jason D. Heming,a Jamie B. Huffman,a Lisa M. Jones,b* Fred L. Homaa
‹Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USAa; Department of Chemistry, Washington
University in St. Louis, St. Louis, Missouri, USAb
During herpes simplex virus 1 (HSV-1) infection, empty procapsids are assembled and subsequently filled with the viral genome
bymeans of a protein complex called the terminase, which is comprised of the HSV-1 UL15, UL28, and UL33 proteins. Biochem-
ical studies of the terminase proteins have been hampered by the inability to purify the intact terminase complex. In this study,
terminase complexes were isolated by tandem-affinity purification (TAP) using recombinant viruses expressing either a full-
length NTAP-UL28 fusion protein (vFH476) or a C-terminally truncated NTAP-UL28 fusion protein (vFH499). TAP of the UL28
protein from vFH476-infected cells, followed by silver staining, Western blotting, andmass spectrometry, identified the UL15,
UL28, and UL33 subunits, while TAP of vFH499-infected cells confirmed previous findings that the C terminus of UL28 is re-
quired for UL28 interaction with UL33 and UL15. Analysis of the oligomeric state of the purified complexes by sucrose density
gradient ultracentrifugation revealed that the three proteins formed a complex with a molecular mass that is consistent with the
formation of a UL15-UL28-UL33 heterotrimer. In order to assess the importance of conserved regions of the UL15 and UL28
proteins, recombinant NTAP-UL28 viruses with mutations of the putative UL28metal-binding domain or within the UL15 nu-
clease domain were generated. TAP of UL28 complexes from cells infected with each domainmutant demonstrated that the con-
served cysteine residues of the putative UL28metal-binding domain and conserved amino acids within the UL15 nuclease do-
main are required for the cleavage and packaging functions of the viral terminase, but not for terminase complex assembly.
Acritical step during productive herpes simplex virus 1(HSV-1) infection is the cleavage and packaging of replicated,
concatemeric viral DNA into preformed capsids. This process has
been shown to require the products of seven viral genes: UL6,
UL15, UL17, UL25, UL28, UL32, and UL33 (1). Many of these
genes have been assigned putative functions based on genetic and
biochemical studies and on similarities between HSV-1 and dou-
ble-stranded DNA (dsDNA) bacteriophage cleavage/packaging
systems (2). The UL6 protein forms a dodecameric complex at one
of the 12 capsid vertices and functions as a portal through which
viral DNA can enter or exit the capsid (3–6). The UL17 and UL25
proteins have recently been shown to form a heterodimeric com-
plex termed the capsid vertex-specific component (CVSC) that
functions at each of the capsid vertices to stabilize DNA-filled
capsids (7–9). The UL32 protein is not well characterized but may
play a role in localizing capsids to sites of DNA packaging (10, 11).
The remaining three proteins, UL15, UL28, and UL33, form a
putative complex within infected cells that functions as the viral
terminase (1).
Difficulties with the purification of the terminase proteins and
the lack of an in vitro cleavage and packaging system in HSV-1 has
hampered studies on the roles of the UL15, UL28, and UL33 pro-
teins in the DNA-packaging reaction. However, cryo-electron mi-
croscopy (EM) and genetic studies have provided several lines of
evidence demonstrating that these proteins function as the HSV-1
terminase. They include studies demonstrating that (i) viral DNA
is not cleaved in HSV-1 mutants encoding mutations that pre-
clude the interaction of UL15 or UL33 with UL28 (12–16), (ii)
HSV-1 recombinants with mutations in the UL6 portal that inter-
fere with the terminase-portal interaction are deficient in cleavage
and packaging of replicated viral DNA (17), (iii) the transient
association of UL15 and UL28 with viral capsids is also observed
with dsDNA bacteriophage terminases (2, 18–21), (iv) human cy-
tomegalovirus (HCMV) mutants displaying resistance to inhibi-
tors of viral DNA cleavage possess mutations within homologs of
UL15 and UL28 (22, 23), and (v) the UL15 and UL28 proteins
contain several conserved domains that are essential for cleavage
and packaging of viral DNA (Fig. 1) (13, 14, 16, 22–34).
UL15 is the most conserved gene within the family Herpesviri-
dae and expresses a protein encoded within two exons of a spliced
transcript (Fig. 1A) (35). Exon I and the N-terminal region of
exon II contain domains typically found in proteins that function
in ATP metabolism, suggesting that these regions provide the mo-
tor function for DNA translocation into the capsid (30, 36–38).
Specifically the Walker A and B box motifs are conserved in ho-
mologs of the UL15 protein found in dsDNA bacteriophages and
are essential for viral DNA cleavage and packaging (26, 30, 36, 38).
Two recent studies have demonstrated that a purified, soluble C-
terminal fragment of the UL15 protein and the HCMV UL89 pro-
tein (a UL15 homolog) possess nuclease activity, and the crystal
structures of both fragments identified metal-coordinating amino
acids that are conserved within herpesvirus UL15 homologs (32,
39). The UL28 protein has been shown to bind specific HSV-1
DNA sequences that are required for cleavage and packaging, and
this function has also been observed with the HCMV UL56 pro-
tein (a UL28 homolog) (40, 41). Furthermore, UL28 encodes a
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putative metal-binding domain that was discovered in HCMV
and shown to contain residues that are conserved among herpes-
virus UL28 homologs (Fig. 1B) (22, 42). The final terminase sub-
unit, UL33, is the least well characterized but may be required for
correct assembly of the terminase complex or may act to regulate
the enzymatic activity of the other subunits during complex func-
tion (13, 15, 16).
Although a great deal of information has been obtained from
genetic studies of the HSV-1 cleavage/packaging genes, several of
these proteins have proven difficult to isolate for biochemical and
structural studies. The goal of the present study was to isolate a
functional terminase complex from HSV-1-infected cells by affin-
ity chromatography, using a virus that expressed the tandem-af-
finity purification (TAP) tag fused to the N terminus of the UL28
protein. TAP resulted in the isolation of soluble UL28 complexes
containing the UL15 and UL33 proteins. The isolated complexes
were characterized using genetic and biochemical approaches to
determine the composition of the complex and the roles of con-
served domains in terminase function. We view these studies as a
critical step in understanding how the terminase complex func-
tions in the context of a productive HSV-1 infection. The discov-
ery of small organic molecules that inhibit herpesvirus replication
by blocking processing and encapsidation demonstrates the valid-
ity of targeting the cleavage/packaging complex for therapeutic
intervention (22, 43). These efforts have led to the discovery of an
HCMV terminase inhibitor (Letermovir) that is presently in phase
III studies (44).
MATERIALS AND METHODS
Cells and viruses. African green monkey kidney (Vero) and UL15-com-
plementing (C2) cell lines were maintained in Dulbecco’s modified
Eagle’s medium supplemented with 5% newborn calf serum, 100 U pen-
icillin per ml, and 100 g streptomycin per ml (growth medium) (29).
UL28-complementing (CV28) cells were maintained exactly like Vero
cells but in medium supplemented with 10% newborn calf serum (15).
The KOS strain of HSV-1 was used as the wild-type virus. The GCB virus,
containing a 1,881-bp deletion within the UL28 open reading frame
(ORF), was described previously (14).
Construction of recombinant viruses. The vFH475 and vFH476 mu-
tant viruses were generated by recombination of a KOS genome main-
tained within a bacterial artificial chromosome (BAC) (Table 1) (45). The
KOS BAC clone was transferred to bacterial strain GS1783, and mutagen-
esis was performed using the two-step bacteriophage Red-mediated ho-
mologous-recombination system (46), as previously described (47). Each
additional mutant virus was generated by the same methods but through
recombination of a bFH476 or bFH503 BAC that was transformed into
GS1783 bacteria (Table 1). A list of the primers and template plasmid
DNA used to amplify the kanamycin resistance constructs will be pro-
vided on request. Plasmids p-EP-TAP-in and p-EP-Kan-S were obtained
from P. Kinchington (University of Pittsburgh). During generation of the
bFH503 BAC, sequencing of the UL28 metal-binding domain region re-
vealed that several clones contained only the C197A mutation, resulting in
the generation of the bFH543 BAC. BAC DNA was transfected into Vero
cells, UL28-complementing CV28 cells, or UL15-complementing C2 cells
(Table 1), and recombinant viruses were harvested from cell lysates and
plaque purified. Insertions, deletions, or base pair changes were con-
firmed by PCR amplification of purified viral DNA using primers that
flank the UL15 or UL28 open reading frames, and the PCR products were
sequenced.
TAP. The TAP protocol was performed by infecting 5 108 Vero cells
with wild-type KOS or recombinant viruses at a multiplicity of infection
(MOI) of 10 PFU/cell. The infection was allowed to proceed for 18 h at
37°C, after which the cells were harvested and pelleted via centrifugation
at 5,000 rpm for 10 min at 4°C. All remaining steps were performed at 4°C.
The cells were washed in a total volume of 50 ml 1 phosphate-buffered
saline (PBS), and the final cell pellet was resuspended in 24 ml of strepta-
vidin binding buffer (SBB) (300 mM KCl, 40 mM Tris-HCl [pH 7.5], 2
mM EDTA, 0.1% NP-40 substitute, and 5 mM -mercaptoethanol) con-
taining protease inhibitors (Roche; catalog no. 1 697 498). The cell sus-
pension was sonicated using a probe sonicator 4 times for 10 s each time at
an output of 6 W with chilling on ice between the sonication steps, result-
ing in a total cell lysate. Benzonase (1,500 U; Novagen; catalog no.
71205-3) was added to the samples and left at 4°C for 30 min. The extract
was then clarified via centrifugation at 12,000 rpm in a Sorvall SS-34 rotor
for 20 min at 4°C. The supernatant was transferred to a new tube, 1.5 ml of
streptavidin resin (0.75-ml packed volume; Pierce; catalog no. 53117) was
added, and the samples were rotated at 4°C for 2 h. The resin was pelleted
by centrifugation at 3,500 rpm for 5 min, and the supernatant was re-
moved. The resin was washed three times by being resuspended in 5 ml of
SBB, followed by centrifugation at 3,500 rpm for 5 min. Protein was eluted
from the resin by adding 3 ml of streptavidin elution buffer (300 mM KCl,
40 mM Tris-HCl [pH 7.5], 2 mM EDTA, 0.1% NP-40 substitute, 5 mM
-mercaptoethanol, 2 mM D-biotin [Sigma; catalog no. 47868]) contain-
ing Roche protease inhibitors, and the sample was rotated at 4°C for 30
min. The protein-resin mixture was spun down at 7,000 rpm in a micro-
centrifuge for 2 min, and the supernatant was collected as the streptavidin
eluate. Twelve milliliters of calmodulin-binding buffer (CBB) (150 mM
NaCl, 10 mM Tris-HCl [pH 7.5], 1 mM magnesium acetate, 1 mM imi-
TABLE 1 Recombinant viruses
Virus no. Virus name BACa Cell lineb
vFH475 NTAP-UL28 KOS Vero
vFH476 CMV-NTAP-UL28 KOS Vero
vFH499 CMV-NTAP-UL28-741s bFH476 CV28
vFH505 CMV-NTAP-UL28(197-225) bFH476 CV28
vFH503 CMV-NTAP-UL28(C197A,C200A) bFH476 CV28
vFH504 CMV-NTAP-UL28(C223A,H225A) bFH476 CV28
vFH542 CMV-NTAP-UL28(C197A,C200A,C223A,H225A) bFH503 CV28
vFH543 CMV-NTAP-UL28(C197A) bFH476 CV28
vFH546 CMV-NTAP-UL28(C197H) bFH476 CV28
vFH506 CMV-NTAP-UL28, UL15(D706A,D707A) bFH476 C2
vFH507 CMV-NTAP-UL28, UL15(D509A) bFH476 C2
a The BAC that was modified to generate the named virus.
b Cell line used for BAC transfection and plaque purification of virus.
FIG1 Conserved UL15 and UL28 protein domains. The schematic depicts the
UL15 (A) and UL28 (B) proteins, with conserved amino acid sequences indi-
cated. All the numbers correspond to amino acid numbers. (A) The gray shad-
ing delineates UL15 exon II from exon I. (B) Conserved cysteine and histidine
residues within the putative UL28 metal-binding domain are underlined.
Heming et al.
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dazole, 2 mM CaCl2, 0.1% NP-40 substitute, 10 mM -mercaptoethanol)
containing Roche protease inhibitors was added to the streptavidin eluate.
An additional 11.25l of 1 M CaCl2 was added to the mixture, along with
1.2 ml of calmodulin resin (0.6-ml packed volume; Agilent Technologies;
catalog no. 214303-52), and samples were rotated at 4°C for 2 h. The resin
was pelleted by centrifugation at 3,500 rpm for 5 min, and the supernatant
was removed. The resin was washed three times by resuspension in 5 ml of
CBB, followed by centrifugation at 3,500 rpm for 5 min. Protein was
eluted from the resin by adding 3 ml of calmodulin elution buffer (150
mM NaCl, 10 mM Tris-HCl [pH 7.5], 1 mM magnesium acetate, 1 mM
imidazole, 0.1% NP-40 substitute, 10 mM -mercaptoethanol, 2 mM
EGTA), and the sample was rotated at 4°C for 30 min. The protein-resin
mixture was spun down at 7,000 rpm in a microcentrifuge for 2 min, and
the supernatant was collected as the final (calmodulin) eluate.
Sucrose gradient ultracentrifugation. UL28 protein complexes were
isolated from vFH476-infected Vero cells by a partial TAP procedure after
elution from the streptavidin resin. The eluted protein sample was con-
centrated 10-fold by column centrifugation (Pierce; catalog no. 89884A).
The concentrated proteins were separated by centrifugation on 2.5 to 20%
sucrose (in 1 PBS) gradients (SW50.1 rotor at 35,000 rpm for 18 h).
Fractions were collected from the bottom to the top of the gradient using
a Beckman fraction recovery system (Beckman; catalog no. 34890). A total
of 33 fractions (130 l each) were collected, and protein was precipitated
by adding an equal volume of 16% trichloroacetic acid. Proteins were
pelleted by centrifugation at 13,000 rpm for 10 min, and the pellets were
resuspended in 30l 2PAGE loading buffer (Invitrogen) supplemented
with 0.4 M Tris base. Odd-numbered protein fractions were resolved on a
4 to 12% SDS-polyacrylamide gel and visualized by Western blotting us-
ing anti-UL28, -UL15, or -UL33 antibodies. Molecular weight control
proteins, aldolase and bovine serum albumin (BSA) (GE Healthcare Life
Sciences), were processed in the same manner but were visualized by
staining with Imperial protein stain (Thermo Scientific; catalog no.
24615).
Mass spectrometry. TAP-purified proteins from vFH476-infected
cells were resolved on a 4 to 12% SDS-polyacrylamide gel and stained with
Imperial protein stain (Thermo Scientific; catalog no. 24615). The stained
gels were sent to Lisa Jones (Washington University in St. Louis, St. Louis,
MO), who performed the remaining mass spectrometry (MS) analysis by
the following methods. The in-gel digest was performed as previously
described (48). Briefly, gel plugs were washed with acetonitrile (Sigma, St.
Louis, MO) in a 96-well plate and rocked for 10 min twice. The samples
were dried in a speed vac for 10 min. A 0.2-g/l stock of trypsin (Sigma,
St. Louis, MO) was made up in 100 l of 1 mM triethyl ammonium
bicarbonate, pH 8.2. Trypsin (5 l) was added to each dried gel plug, and
the plate was incubated at 58°C for 30 min. After digestion, 1 l of 1%
acetonitrile with 1% formic acid was added to each gel plug, and the plate
was incubated at 37°C for 1 h. The solution from each 96-well plate was
transferred to autosampler vials and centrifuged at 10,000 rpm for 40 min.
To reduce keratin contamination, the in-gel digest was performed in a
laminar flow hood. The digested samples were loaded onto a 100-m by
2-cm Acclaim PepMap100 C18 nanotrap column (5 m; 100 Å; Thermo
Scientific, Pittsburgh, PA) with an Ultimate 3000 liquid chromatograph
(Thermo Scientific, Pittsburgh, PA) at 8 l/min. The peptides were sepa-
rated on a silica capillary column that was custom packed with C18 re-
verse-phase material (Magic; 0.075 mm by 150 mm; 5 m; 120 Å;
Michrom Bioresources, Inc., Auburn, CA). The gradient was pumped at
260 nl/min from 0 to 80% solvent B (20% water, 80% acetonitrile, 0.1%
formic acid) for 60 min and then to 80% solvent B for 7 min and reequili-
brated to solvent A (water, 0.1% formic acid) for 10 min. The mass spec-
trometry was performed on an LTQ-FT-ICR Ultra (Thermo-Fisher, Pitts-
burgh, PA). The mass spectrometer was operated in data-dependent
acquisition mode controlled by Xcalbur 2.0.7 software. Peptide mass
spectra were acquired from an m/z range of 350 to 2,000 at high mass
resolving power. The top six most abundant multiply charged ions with
minimum signal intensity at 800 counts were subjected to collision-in-
duced dissociation (CID) in the linear ion trap. Charge state rejection of
1 ions was employed. Precursor activation was performed with an iso-
lation width of 2 Da and an activation time of 30 ms. The raw data were
aligned and converted into a centroided peaklist file by Progenesis LC-MS
(Nonlinear Dynamics, Durham, NC) (49). The files were searched using
MASCOT 2.2.06 (Matrix Science, London, United Kingdom). The en-
zyme specificity was set to trypsin with 2 missed cleavages. The mass
tolerances for precursor and fragment ions were 12 ppm and 0.6 Da,
respectively. Oxidation of methionine was specified in Mascot as a vari-
able modification. The data were searched against the NCBI 20120108
database. A threshold of 5% probability that protein identification was
incorrect was implemented. Scaffold_3_00_08 (Proteome Software Inc.,
Portland, OR) was used to validate tandem mass spectrometry (MS-MS)-
based peptide and protein identifications. Peptide identifications were
accepted if they could be established at greater than 95.0% probability, as
specified by the Peptide Prophet algorithm (50). Protein identifications
were accepted if they could be established at greater than 99.0% probabil-
ity and contained at least 2 identified peptides. Protein probabilities were
assigned by the Protein Prophet algorithm (51).
Western blotting. Protein samples were separated on a 4 to 12% SDS-
polyacrylamide gel and transferred to nitrocellulose. The nitrocellulose
was washed twice in Tris-buffered saline (TBS) and incubated overnight
in Rockland Near Infra-Red blocking buffer (Rockland Immunochemi-
cals; catalog no. MB-070-003). The primary antibodies used (dilutions in
parentheses) include UL28 rabbit polyclonal antibody UL28 – glutathione
S-transferase (GST) (1:1,000) (52); VP5 rabbit polyclonal antibody NC1
(1:5,000) (53); rabbit monoclonal anti-calmodulin-binding protein
epitope tag antibody, clone C16T (1:3,000) (Millipore; catalog no. 05-
932); UL15 rabbit polyclonal antibody UL15-GST(1-104) (1:1,000) (54);
and UL33 rabbit polyclonal antibody UL33-GST (1:500) (55). The
blocked nitrocellulose was reacted with the diluted antibodies for 2 h at
room temperature, washed five times in TBS with 0.5% Tween 20, and
incubated with IRDye 800-conjugated goat anti-rabbit secondary anti-
body (Rockland Immunochemicals) diluted 1:15,000 in Rockland Near
Infra-Red blocking buffer with 0.1% Tween 20. The blots were washed
and scanned using an Odyssey system (Li-Cor, Lincoln, NE). Integrated
intensity values were obtained using Odyssey software version 3.0 (Licor,
Lincoln, NE).
Southern blotting. T-175 flasks of Vero, CV28, or C2 cells (3 107
cells per flask) were infected with virus at an MOI of 5 PFU per cell. At 18
h postinfection (p.i.), the medium was removed and the cells were washed
in 1 phosphate-buffered saline. Cells were harvested by scraping them
from the plate and pelleted. The cells were lysed, and total cell DNA or
DNase-resistant DNA samples were prepared as previously described (56,
57). The final DNA was digested with BamHI to assess the cleavage of viral
DNA. DNA was separated by agarose gel electrophoreses, transferred to a
nylon membrane, and hybridized as previously described (56). Southern
blots were scanned with a Storm 840 PhosphorImager.
RESULTS
Characterization of NTAP-UL28 virus. Previous studies have
shown that the amino terminus of UL28 is not essential for virus
growth and can tolerate the insertion of foreign epitopes (13).
Therefore, the TAP tag was inserted at the amino terminus of
UL28. The 78-amino-acid TAP tag used for these studies has been
previously described (8) and consists of a streptavidin-binding
peptide and a calmodulin-binding peptide. The TAP tag was in-
serted at the N terminus of the UL28 open reading frame through
manipulation of an HSV-1 (KOS) genome maintained within a
recombinant BAC (Fig. 2).
The BAC was transfected into Vero cells, and the recovered
virus, vFH475, was plaque purified on Vero cells. Two additional
HSV-1 UL28 recombinant viruses, vFH476 and vFH499, were
generated in the same manner. vFH476 expresses an NTAP-UL28
HSV-1 Terminase Complex
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protein under the transcriptional control of the cytomegalovirus
(CMV) immediate-early promoter, and vFH499 expresses a C-
terminally truncated NTAP-UL28 protein under CMV promoter
control (Fig. 2). The truncation in vFH499 is the result of an in-
sertion of a linker sequence containing an in-frame stop codon
after amino acid 741 of UL28. We previously reported that this
truncation precludes the interaction of both the UL15 and UL33
proteins with UL28 (13). The recovered viruses were plaque puri-
fied on Vero (vFH475 and vFH476) or UL28-complementing
CV28 (vFH499) cells, virus stocks were prepared, and their titers
were determined. The vFH475 and vFH476 viruses yielded similar
titers on Vero and CV28 cells, while the vFH499 virus, which
expresses a nonfunctional UL28 protein, formed plaques only on
CV28 cells (Table 2). Intracellular replication of each recombi-
nant virus was compared to that of wild-type KOS virus by estab-
lishing single-step growth curves in Vero and CV28 cells. Cells
were infected with each virus at an MOI of 1; harvested at 0, 2, 4, 7,
10, 22, and 30 h p.i.; and assayed for infectious virus by plaque
assay on CV28 cells (Fig. 3). When grown on Vero or CV28 cells,
the vFH475 and vFH476 virus titers were reduced (1 to 2 log units)
compared to KOS. The vFH499 virus failed to produce virus on
Vero cells but grew to nearly wild-type levels on CV28 cells. Taken
together, these results demonstrate that the vFH475 and vFH476
viruses grow on noncomplementing cells, but addition of the fu-
sion protein reduces the overall virus yield, while expression from
the CMV promoter does not appear to affect virus growth.
NTAP-UL28 protein expression was examined for vFH475,
vFH476, and vFH499 by Western blotting and compared to UL28
protein expression from the wild-type KOS virus. Infected Vero
cell lysates were isolated at 18 h p.i. and probed with a UL28
antibody (Fig. 4A). The UL28 protein expressed by KOS resolved
in SDS-PAGE with an apparent molecular mass of 86 kDa, and
each recombinant virus expressed a UL28 protein with mobility
corresponding to the expected molecular mass. NTAP-UL28 pro-
teins expressed by vFH475 and vFH476 exhibited slightly lower
mobility than KOS, corresponding to the additional 78 amino
acids (approximately 8.6 kDa) of the TAP tag, while the NTAP-
UL28 protein expressed from vFH499 was slightly smaller than
that from vFH475 and vFH476 due to the truncation of 44 amino
acids from the UL28 C terminus.
Total cell extracts from KOS-, vFH475-, vFH476-, and
vFH499-infected Vero cells were prepared at 0, 2, 4, 7, 10, 22, and
30 h p.i., and expression of the UL28 gene product was analyzed by
Western blotting (Fig. 4B). In KOS-infected Vero cells, the 86-kDa
FIG 2 Recombinant UL28 virus constructs. The HSV-1 genome is shown at
the top, with the long and short unique regions represented as UL and US,
respectively. The UL28 open reading frame from wild-type KOS or each re-
combinant virus is expanded below, with virus names and protein sizes indi-
cated on the left of each construct. The amino acid numbers below each con-
struct indicate protein lengths. The vFH499 virus contains a nonsense
mutation of amino acid 741.
TABLE 2 Virus growth assay
Virus no.
Virus plating efficiency (PFU/ml) ina:
Vero cells CV28 cells C2 cells
KOS 5.9 109 9.8 108 6.7 109
vFH475 3.1 109 3.8 108 ND
vFH476 2.8 1010 2.1 109 ND
vFH499 1,000 2.9 109 ND
vFH505 1,000 3.1 108 ND
vFH503 1,000 1.2 1010 ND
vFH504 1 105 2.25 108 ND
vFH542 1 105 1.55 108 ND
vFH543 1,000 2.1 1010 ND
vFH546 1,000 3.6 109 ND
vFH506 5 104 ND 7 108
vFH507 1,000 ND 1.75 109
a ND, not determined.
FIG3 Recombinant NTAP-UL28 virus single-step growth curves. Vero (A) or
CV28 (B) cells were infected with the indicated HSV-1 recombinant viruses or
with wild-type (KOS) virus at an MOI of 1 at 4°C for 1 h and incubated at 37°C.
The cultures were harvested at the indicated times postinfection and freeze-
thawed, and the virus yield at each time point was determined by the plaque
titer on CV28 cells.
Heming et al.
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UL28 protein was first detected at 7 to 10 h p.i., and the intensity of
this band showed a moderate increase at later times postinfection.
The recombinant viruses expressing the 95-kDa (vFH475 and
vFH476) and 90-kDa (vFH499) NTAP-UL28 fusion proteins
showed a pattern of expression similar to that of the KOS UL28
protein. However, expression of the NTAP-UL28 gene from the
CMV promoter (vFH476 and vFH499) resulted in increased levels
of the UL28 fusion protein compared to KOS and vFH475. The
blots were stripped and probed for the major capsid protein VP5,
demonstrating that similar amounts of cell extracts were loaded.
These results demonstrate that placing the NTAP-UL28 fusion
under CMV promoter control resulted in an increase in UL28
protein levels without altering the kinetics of expression. Since the
goal of these studies was to purify and characterize the HSV-1
terminase complex via affinity purification of the NTAP-UL28
protein, the recombinant viruses expressing NTAP-UL28 under
CMV promoter control were utilized for the remainder of these
studies.
Tandem-affinity purification of NTAP-UL28 protein com-
plexes. TAP is a dual purification procedure that allows the effi-
cient isolation of protein complexes under native conditions (58).
The TAP procedure was utilized to isolate the putative HSV-1
terminase complex of UL15, UL28, and UL33 from infected cells
via the NTAP-UL28 fusion protein. Vero cells were infected with
NTAP-UL28 viruses or KOS at an MOI of 10, and cell extracts
were harvested at 18 h p.i. and subjected to the TAP procedure
(Fig. 5). The TAP tag utilized in these studies encodes a calmodu-
lin-binding domain and a streptavidin-binding domain (Strat-
agene-Interplay). Infected-cell extracts were incubated with
streptavidin resin, and interacting complexes were eluted with
biotin and then incubated with calmodulin resin in the presence
of calcium and eluted with EGTA. Silver stain of the final calmo-
dulin-eluted samples revealed a major band at approximately 95
kDa in the vFH476 lane, corresponding to the full-length NTAP-
UL28 fusion protein, and a band at 90 kDa in the vFH499 lane,
which corresponds to the truncated NTAP-UL28 protein (Fig.
5A). Bands observed in the KOS lane represent proteins that in-
teract nonspecifically with the TAP resins, while additional bands
in the vFH476 and vFH499 lanes represent proteins that copurify
with the tagged complex. Western blot analysis identified the pu-
tative terminase subunits, UL15 and UL33, in complexes contain-
ing the full-length UL28 protein but, as expected, not in com-
plexes containing the UL28-741s truncation mutant (Fig. 5B).
Note that both the UL15 and UL33 proteins were also readily
observed by silver staining in vFH476-infected cells. Blots for
UL28 and the calmodulin-binding peptide confirmed that each
FIG 4 Recombinant NTAP-UL28 fusion protein expression. (A) Vero cells
were infected with wild-type (KOS) virus or the indicated HSV-1 recombinant
viruses at an MOI of 10. At 18 h postinfection, cell lysates were harvested and
resolved by SDS-PAGE, and Western blots were probed with a UL28 antibody.
Protein standards (kDa) are shown on the left of the blot. (B) Vero cells were
infected with wild-type (KOS) virus or the indicated HSV-1 recombinant vi-
ruses at an MOI of 1 at 4°C for 1 h and incubated at 37°C. Infected-cell lysates
were harvested at the indicated times postinfection and resolved by SDS-
PAGE, and Western blots were probed with UL28 and VP5 antibodies. VP5 is
the major capsid protein and serves as a loading control between samples.
FIG5 TAP of NTAP-UL28 fusion proteins. Vero cells were infected with the indicated HSV-1 recombinant viruses or with wild-type (KOS) virus. (A) After TAP,
proteins eluted from the calmodulin column were resolved by SDS-PAGE and identified by silver staining. (B) Immunoblots (antibodies are listed below each
blot; CalBP, calmodulin-binding peptide antibody) demonstrating the presence of each TAP-tagged protein. Protein standards (kDa) are shown on the left of
each gel or blot.
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major band observed by silver stain contained the NTAP-UL28
protein in both the vFH476 and vFH499 lanes, and additional
bands at approximately 63, 50, and 43 kDa were observed that may
represent cleavage or degradation products of the UL28 protein.
In summary, these results indicate that TAP of the UL28 protein is
an effective method for the efficient purification of the putative
terminase complex of UL28, UL15, and UL33.
Oligomeric state of TAP-purified terminase components.
The oligomeric state of TAP-purified terminase components was
examined by sucrose density gradient ultracentrifugation (Fig. 6).
In order to increase the amount of input protein and minimize
sample manipulation, a partial TAP procedure was performed in
which UL28 complexes were isolated from vFH476-infected cells
using only the initial streptavidin-binding and elution steps. The
purified proteins were separated on 2.5 to 20% sucrose gradients,
and fractions were collected from the bottom to the top of the
gradient. A total of 33 fractions were collected and analyzed by
SDS-PAGE and Western blotting for the UL15, UL28, and UL33
proteins (Fig. 6A). Molecular mass control proteins, aldolase and
BSA (158 and 66 kDa, respectively), were subjected to identical
centrifugation and fractionation conditions, and their relative po-
sitions in each gradient were determined by SDS-PAGE and Coo-
massie staining (data not shown). Immunoblots were analyzed by
densitometry, and the values obtained for each fraction were plot-
ted on the same graph, revealing three distinct peaks (Fig. 6B). In
fraction 11, a protein complex composed of the UL15, UL28, and
UL33 proteins in a 1:1:1 ratio would be expected to possess a
molecular mass of approximately 190 kDa, while in fraction 17, a
1:1 complex of UL28 and UL33 would be approximately 109 kDa.
The proposed size of each complex is consistent with the relative
migration of the molecular mass standards. The observation of the
UL33 protein alone in fraction 27 may suggest that the protein
possesses a weaker affinity for UL28 and readily dissociates from
the complex. Taken together, sucrose gradient centrifugation of
UL28 complexes purified by TAP from vFH476-infected cells re-
vealed a complex composed of the UL15, UL28, and UL33 pro-
teins.
Mass spectrometry analysis of UL28 complexes. Numerous
protein bands were observed that copurify with UL28 complexes
by TAP (Fig. 5). One goal of this study was to characterize the
proteins that were isolated as components of the terminase com-
plex. In order to identify those proteins, UL28 complexes were
purified from vFH476-infected Vero cells. The purified protein
complexes were resolved by SDS-PAGE and stained, and bands
corresponding to the NTAP-UL28, -UL15, and -UL33 proteins
were isolated and confirmed by liquid chromatography (LC)
MS-MS (Fig. 7). Also of particular interest were those bands cor-
responding to sizes of approximately 150, 63, and 50 kDa (un-
knowns 1 to 3, respectively) which were also observed as predom-
inant bands by silver staining (Fig. 5). LC MS-MS analysis
determined unknown 1 to be the VP5 major capsid protein, while
unknowns 2 and 3 consisted of peptides from UL28. The VP5
band was confirmed by Western blotting (data not shown). The
UL28 peptides were present in TAP preparations from both the
FIG 6 Sedimentation velocity analysis of TAP-purified UL28 complexes.
Complexes from vFH476-infected Vero cells were purified through the initial
streptavidin column, layered onto a 2.5 to 20% sucrose gradient, and centri-
fuged at 35,000 rpm at 4°C for 18 h. The gradient was fractionated, and indi-
vidual fractions were resolved by SDS-PAGE, followed by immunoblotting
(antibodies are listed beside each blot) (A) and densitometry (B). (B) Inte-
grated intensity values were obtained for each band using Odyssey software
version 3.0 (Licor, Lincoln, NE). Control proteins, aldolase and BSA (GE
Healthcare Life Sciences), were subjected to identical centrifugation and frac-
tionation conditions, and their relative positions in each gradient, as indicated,
were determined by SDS-PAGE and Coomassie staining (data not shown).
FIG 7 Mass spectrometry analysis of isolated NTAP-UL28 fusion proteins.
(A) Vero cells were infected with vFH476, and at 18 h p.i., UL28 complexes
were purified by TAP. The isolated complexes were resolved by SDS-PAGE
and stained using Imperial stain. Protein standards (kDa) are shown on the left
of the gel. (B) The indicated protein bands in panel A were excised from the gel
and analyzed by LC MS-MS with molecular masses and amino acid (aa) counts
from databases.
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vFH476- and vFH499-infected cells, and these peptides are most
likely the result of cleavage in the C terminus of UL28, since both
of the truncated proteins were found to react with UL28 and calm-
odulin-binding peptide antibodies (Fig. 5).
Effects of mutations in the UL15 nuclease domain and puta-
tiveUL28metal-binding regionon terminase formation and ac-
tivity. The vFH476 BAC was utilized to generate additional
HSV-1 recombinants that express the full-length or C-terminally
truncated NTAP-UL28 fusion protein but that also encode muta-
tions within the nuclease domain of UL15 or the proposed metal-
binding domain of UL28 (Fig. 8 and Table 1). Sequence analysis of
a number of UL28 protein homologs indicated that a highly con-
served region from amino acids 197 to 225 resembled a putative
zinc finger motif: C197-X2-C200-X22-C223-X-H225 (22, 42). In
order to determine the importance of this region, we generated
recombinant viruses that contained a deletion or amino acid sub-
stitutions within amino acids 197 to 225 of UL28 (Fig. 8A). The
UL28 mutations were introduced into the viral genome through
genetic manipulation of the vFH476 BAC. The deletion removed
the coding sequence for amino acids 197 to 225 of the UL28 ORF
to generate the vFH505 mutant virus. Amino acids C197, C200,
C223, and H225 are conserved and most likely correspond to the
metal-coordinating amino acids within the zinc finger motif pre-
dicted for this region of UL28 (22, 42). Mutations either individ-
ually (C197A or C197H), in pairs (C197A and C200A or C223A
and H225A), or as a quadruple mutant (C197A, C200A, C223A,
and H225A) were introduced into this region to generate the
vFH543, vFH546, vFH503, vFH504, and vFH542 mutant viruses,
respectively (Fig. 8A). Two additional viruses, vFH506 and
vFH507, were generated with mutations resulting in amino acid
changes within the UL15 conserved nuclease domain of the
vFH476 BAC (Fig. 8B). Three acidic residues, D509, E581, and
D707, form the conserved triad in the UL15 nuclease active site
that coordinate binding of Mg2, which is essential for the DNA
cleavage reaction carried out by the UL15 protein (32, 39). The
vFH506 virus expresses a UL15 protein that contains D706A and
D707A amino acids changes, and vFH507 contains a D509A
amino acid substitution. All of the recombinant viruses contain-
ing UL28 or UL15 domain mutations grew only on their respec-
tive complementing cell lines, indicating that each virus expressed
a nonfunctional UL15 or UL28 protein (Table 2).
To determine whether the viruses bearing UL15 or UL28 do-
main mutations were impaired in DNA cleavage and packaging,
viral DNA processing was investigated by Southern blotting. Dur-
ing viral DNA replication, concatemeric DNA is cleaved into unit
length molecules and packaged into virions. The presence of chro-
mosomal ends can be monitored by Southern blotting of total
infected-cell DNA digested with BamHI and probed with the
HSV-1 BamHI K fragment. Only encapsidated viral DNA with
free chromosomal ends will give rise to the terminal BamHI Q and
S fragments, along with the joint-spanning K fragment (Fig. 9A).
If the cell extract is DNase treated prior to DNA isolation, only
packaged viral DNA will be detected in the Southern blots. The
viral K, Q, and S fragments were detected with DNA isolated from
Vero cells infected with the wild-type KOS virus and with the
FIG 8 Recombinant UL28 and UL15 virus constructs. (A) UL28 protein ex-
pressed from vFH505 or vFH476, with protein sizes indicated on the left of
each construct. The amino acid numbers below each construct indicate dele-
tion of the indicated amino acids () or protein length. The metal-binding
domain of vFH476 is expanded to show the amino acid sequence. Recombi-
nant viruses containing site-specific mutations within the metal-binding do-
main of UL28 are shown below, with virus names on the left. The underlined
residues are conserved among the herpesviruses, and the double-underlined
residues are mutated amino acids. (B) HSV-1 genome (top), with the long and
short unique regions represented (UL and US, respectively). The UL15 protein
expressed from wild-type HSV-1 KOS or each recombinant virus is expanded
below, with virus names and protein sizes indicated on the left of each con-
struct. The amino acid numbers below each construct indicate mutation of the
indicated amino acid or protein length.
FIG 9 Analysis of viral DNA packaging. (A) Locations of the BamHI K joint-
spanning fragment and the two end fragments, BamHI-Q and -S, in the HSV-1
genome. (B) Vero, CV28, or C2 cells were infected with the indicated virus at
an MOI of 5 PFU per cell. At 18 h p.i., DNase I-protected total infected-cell
DNA was isolated, digested with BamHI, and subjected to Southern blot anal-
ysis using the BamHI K fragment (32P labeled) as a probe.
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NTAP-UL28 virus (vFH476). These fragments were not detected
with a UL28-null virus (GCB), the C-terminally truncated UL28
virus (vFH499), or the UL28 (vFH505) and UL15 (vFH506 and
vFH507) domain mutants (Fig. 9B). When the infections were
performed on UL28 (CV28)- or UL15 (C2)-complementing cell
lines, packaged DNA was readily detected with the UL28 or UL15
mutants (Fig. 9B), indicating that the replication defects with
these viruses were due to impaired DNA cleavage and packaging.
In order to determine if the UL15 or UL28 domain mutations
affected terminase complex formation, UL28 protein complexes
were purified from infected cells by TAP. Vero cells were infected
with either the wild-type KOS virus, the parental NTAP-UL28
virus (vFH476), or the UL28 (vFH505) and UL15 (vFH506,
vFH507) domain mutant viruses at an MOI of 10. At 18 h p.i., cell
extracts were harvested and subjected to the TAP procedure.
Western blotting of the final calmodulin-eluted samples using an-
tibodies against UL28 revealed the full-length 95-kDa NTAP-
UL28 protein for vFH476 and a smaller NTAP-UL28 protein of
approximately 92 kDa for vFH505 due to the deletion of the pu-
tative metal-binding domain (Fig. 10). The UL15 domain mutants
(vFH506 and vFH507) were also found to express a full-length
NTAP-UL28 protein. Blots were also probed for the UL15 and
UL33 proteins to determine if the domain mutations affected ter-
minase complex formation. Both UL15 and UL33 were copurified
using the full-length NTAP-UL28 virus (vFH476), as previously
observed (Fig. 5), and were also associated with purified com-
plexes containing the deletion of the putative metal-binding do-
main within the NTAP-UL28 fusion (vFH505). The mutated
UL15 proteins encoded by vFH506 and vFH507 were shown to
copurify with UL28 complexes, as well as the UL33 protein. No
terminase subunits were purified from lysates of KOS-infected
cells, confirming the specificity of the TAP procedure. Of note, the
levels of each terminase complex subunit purified from cells in-
fected with the UL28 and UL15 mutants (vFH505, vFH506,
vFH507) appears to be decreased relative to the levels found with
the full-length NTAP-UL28 virus (vFH476). These results dem-
onstrated that the UL15 and UL33 proteins copurify with UL28 in
all samples, indicating that the mutations introduced within the
nuclease domain of UL15 or the metal-binding domain of UL28
do not preclude terminase complex formation.
Finally, Western blot analysis of UL28 complexes purified by
TAP revealed the purification of several truncated forms of UL28
(Fig. 5 and 7), and mass spectrometry confirmed that fragments
migrating in SDS-PAGE at approximately 63 and 50 kDa were
composed of UL28 peptides. In the current analysis, blotting for
UL28 or the calmodulin-binding peptide demonstrated the pres-
ence of the same truncated forms of the NTAP-UL28 protein with
the viruses expressing mutated UL15 proteins (vFH506 and
vFH507) (Fig. 10). In contrast, the vFH505 virus contains a faint,
smaller, truncated NTAP-UL28 protein of approximately 60 kDa
due to the 29-amino-acid deletion of the putative metal-binding
domain of UL28. The detection of these proteins in each sample
using the calmodulin-binding peptide antibody suggests that the
63- and 60-kDa NTAP-UL28 proteins are the result of the loss of
approximately 30 to 35 kDa (300 amino acids) from the C ter-
minus of UL28.
DISCUSSION
A productive HSV-1 infection requires the UL28, UL15, and UL33
gene products for cleavage and packaging of replicated, concate-
meric viral DNA into capsids. These proteins comprise a viral
terminase complex similar in function to those utilized by dsDNA
bacteriophages (1, 2). Terminases are powerful molecular motors
that are required to drive DNA into the capsid against the strong
repellent molecular charges in tightly packaged viral DNA (59).
Biochemical analysis of the HSV-1 terminase has proven difficult
due to the inability to purify the complex subunits, particularly
UL15 and UL28. In this study, we purified the terminase complex
from cells infected with HSV-1 recombinants expressing the UL28
protein fused to an N-terminal TAP tag. Additionally, mutations
or deletions within the nuclease domain of UL15 or the metal-
binding domain of UL28 were introduced into the genome of the
FIG 10 TAP and immunoblot of UL28 complexes purified from UL15 and UL28 domain mutant viruses. Vero cells were infected with the indicated HSV-1
recombinant viruses or with wild-type (KOS) virus. After TAP, proteins eluted from the calmodulin column were resolved by SDS-PAGE and identified by
Western blotting (antibodies are listed below each blot; CalBP, calmodulin-binding peptide antibody). Protein standards (kDa) are shown on the left of each blot.
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NTAP-UL28 fusion virus. Biochemical and genetic analysis of iso-
lated UL28 complexes was performed in order to determine ter-
minase complex composition and to examine the effects of do-
main mutations on complex formation and function during
HSV-1 infection.
Addition of the TAP tag to the N terminus of UL28 (vFH475)
did not alter UL28 protein expression kinetics but reduced virus
growth by approximately 2 log units compared to wild-type KOS
virus. Western blotting of vFH475-infected cell lysates revealed
relatively low-level UL28 protein expression similar to that ob-
served with wild-type KOS virus. Therefore, a second recombi-
nant virus, vFH476, was constructed that expresses the NTAP-
UL28 fusion protein under the transcriptional control of the
human CMV immediate-early gene promoter in order to increase
UL28 protein expression levels. Compared to vFH475 or wild-
type KOS, vFH476 expressed the NTAP-UL28 fusion protein with
similar kinetics but in increased amounts more suitable for down-
stream biochemical and proteomic analysis. Single-step growth
curves of vFH476 revealed a similar decrease in the virus titer
(approximately 2 log units), as was found with the vFH475 virus,
indicating that CMV promoter overexpression did not affect virus
growth. It is not known why the addition of the TAP tag reduced
growth of vFH475 and vFH476 relative to KOS virus growth, al-
though it is possible that the addition of 78 amino acids to the N
terminus of UL28 (the TAP tag) resulted in a steric hindrance to
complex assembly or function (i.e., the terminase interaction with
replicated viral DNA).
TAP of UL28 complexes from vFH476- or vFH499-infected
cells followed by silver staining and Western blotting confirmed
that the UL33 and UL15 proteins were copurified in complexes
containing the full-length UL28 protein (vFH476) but, as ex-
pected, not from complexes containing the UL28-741s truncation
mutant (vFH499). Mass spectrometry analysis of specific SDS-
PAGE bands confirmed the presence of the UL15, UL28, and
UL33 proteins in purified UL28 complexes from vFH476-infected
Vero cells, providing further evidence that these proteins are com-
ponents of the HSV-1 terminase complex.
Mass spectrometry was also utilized to identify three unknown
proteins that copurified with UL28 complexes from vFH476-in-
fected Vero cells. Two unknown proteins migrating at approxi-
mately 63 and 50 kDa were revealed to consist of UL28 peptides.
These truncated UL28 bands were also detected by Western blot-
ting of TAP-purified UL28 complexes from each of the NTAP-
UL28 fusion viruses examined by immunoblotting (vFH476,
vFH499, and vFH505 to vFH507), and the detection of these trun-
cated proteins using either the UL28 or calmodulin-binding pep-
tide antibodies suggests the loss of approximately 30 to 35 kDa
(300 amino acids) from the C terminus of UL28. However, it is
unclear whether these bands are the result of protein degradation
during purification or are specific cleavage events. Identification
of the VP5 major capsid protein as the third unknown protein is
not surprising. The terminase associates with capsids during the
DNA encapsidation process (1), and it is possible that partial or
intact viral capsids are purified during TAP, which suggests that
VP5 interacts only indirectly with the viral terminase. The results
of the mass spectrometry analysis further confirm that only the
viral UL15, UL28, and UL33 proteins appear to compose the ter-
minase complex, maintaining the potential importance of the ter-
minase as a target for novel antiviral compounds. However, this
analysis included only proteins within specific gel slices, and a
more comprehensive analysis of the entire purified sample may
reveal additional terminase complex components.
Sucrose density gradient ultracentrifugation of purified com-
plexes revealed significant amounts of the UL15, UL28, and UL33
proteins comigrating in a size range greater than 158 kDa. This
size range is consistent with a 1:1:1 complex of UL15, UL28, and
UL33 that possesses an approximate molecular mass of 190 kDa.
These data are in agreement with a previous study demonstrating
that interacting UL15 and UL28 subunits purified from HSV-1-
infected cells comigrate through a sucrose gradient to a position
consistent with a 1:1 heterodimer of both proteins (60). It is im-
portant to note that at the time of this study the UL33 protein was
not yet implicated as an HSV-1 terminase subunit. The observa-
tion of what may be UL28-UL33 heterodimers is consistent with
previous studies suggesting that the UL28-UL33 interaction en-
hances the interaction of UL15 with UL28 and increases the num-
ber of properly formed complexes (13, 15, 16). However, it must
be noted that the presence or absence of UL15-UL28 heterodimers
is difficult to determine, as these complexes would migrate to a
gradient position similar to that of the UL15-UL28-UL33 hetero-
trimer, due to the small size of UL33 (14kDa). The observation
of a gradient fraction containing monomeric UL33 may suggest
that the protein possesses lower affinity and can readily dissociate
from the complex. However, UL33 dissociation may also be the
result of in vitro conditions, and it might be interesting to alter the
stringency of either the TAP or gradient centrifugation method to
further examine the effect on terminase complex stoichiometry.
Several amino acid domains implicated in mediating termi-
nase complex formation and function(s) have been identified
within the UL15 and UL28 subunits, and these domains are con-
served across the herpesviruses (22, 32, 36, 61). In this study, mu-
tations or deletions within the nuclease domain of UL15 or the
metal-binding domain of UL28 were introduced into the genome
of the NTAP-UL28 fusion virus (vFH476) in order to determine
the importance of these regions in terminase complex formation
and function during HSV-1 infection. Viruses encoding muta-
tions within UL15 amino acids 509 or 706 and 707 (vFH507 and
vFH506, respectively) replicated only on UL15-complementing
cell lines, and both viruses were deficient in the cleavage and pack-
aging of viral DNA, but not in assembly of the terminase complex.
These results are consistent with a recent study that demonstrated
that mutation of these conserved residues within the UL15 ho-
molog in HCMV, UL89, disrupted the nuclease activity displayed
by a purified C-terminal fragment of the UL89 protein (32). The
crystal structure of C-terminal fragments for the UL15 and UL89
proteins revealed that these proteins use an RNase H-like, metal
ion-mediated catalysis mechanism for cleavage of viral concate-
meric DNA (32, 39).
In the current analysis, it seems likely that the loss of DNA
cleavage and packaging activity observed in the UL15 mutant vi-
ruses (vFH506 and vFH507) is due to the disruption of metal ion
coordination, and further experiments will include examining the
nuclease activities of these mutants.
The UL28 protein is implicated as the DNA-binding subunit of
the HSV-1 terminase and contains a domain resembling a puta-
tive zinc finger motif (C197-X2-C200-X22-C223-X-H225) (22,
42). This domain is critical for proper terminase function, as a
recombinant virus encoding a deletion of the putative metal-
binding domain (vFH505) replicated to high titers only on a
UL28-complementing cell line and was deficient in DNA cleavage
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and packaging. UL28 amino acids C197, C200, C223, and H225
are conserved and most likely correspond to the metal-coordinat-
ing amino acids within the zinc finger motif predicted for this
region of UL28. Point mutation of these amino acids ether singly,
in pairs, or as a quadruple mutant (vFH503, vFH504, vFH542,
vFH543, and vFH546) resulted in viruses that replicated to high
titers only on a UL28-complementing cell line. This result is par-
ticularly surprising for vFH546, which encodes a C197H substitu-
tion, as the histidine substitution is not expected to preclude metal
ion coordination. This may suggest that this domain plays a struc-
tural role, where disulfide bond formation between cysteine resi-
dues is critical to terminase assembly and/or function. The termi-
nase complexes of several dsDNA bacteriophages consist of
interacting small and large subunits, and the functional terminase
holoenzyme is a multimeric complex of these proteins (62); there-
fore, UL28 may form intersubunit disulfide bonds to assemble
and/or stabilize higher-order terminase structures. Intersubunit
disulfide bonds have also been shown to be required for the sta-
bility and/or formation of UL6 portal rings (63). It is also possible
that intersubunit disulfide bond formation may be occurring be-
tween UL28 and another capsid-associated protein, such as the
UL6 portal, which would account for the loss of DNA cleavage and
packaging observed with the UL28 metal-binding domain dele-
tion mutant (vFH505). However, if this is the case, it does not
appear that disulfide bond formation is essential for the interac-
tion of UL15 and/or UL33 with UL28, as both subunits were
shown to associate with UL28 complexes purified from the do-
main deletion virus (vFH505).
Several important questions remain concerning the biochem-
ical activity and localization of the purified terminase complexes.
The TAP done in the present study was performed starting with
total infected-cell lysates, since this resulted in higher yields of the
isolated complex. We performed the TAP starting with isolated
nuclei and found the three-protein complex was present in both
the cytoplasm and nuclei of cells infected with the full-length
NTAP-UL28 fusion protein (data not shown). In contrast, the
C-terminally truncated NTAP-UL28 fusion protein (vFH499)
was found exclusively in the cytoplasm. These data are consistent
with previous studies showing that the UL15-UL28-UL33 com-
plex forms in the cytoplasm and that the nuclear localization sig-
nal in UL15 is used to import the complex into the nucleus (27).
Preliminary studies to test for biochemical activities associated
with the isolated terminase complexes have demonstrated that the
full-length UL28 complexes (vFH476) showed robust nuclease
activity in the presence of Mn2 or Mg2, but not with Ca2 ions,
while no activity was found with the KOS control sample. Surpris-
ingly, however, complexes isolated using the UL28 C-terminal
truncation mutant (vFH499) also showed nuclease activity. Our
present studies are focused on determining if UL28 alone pos-
sesses nuclease activity or if the activity is due to a cell nuclease that
copurifies with the complex.
In conclusion, these results have demonstrated that TAP of an
NTAP-UL28 fusion protein can be utilized to isolate the endoge-
nous terminase complex from HSV-1-infected cells. This method
should allow further biochemical analysis of purified complexes
and demonstration of the cleavage and packaging functions at-
tributed to the viral terminase. These results have also demon-
strated the ability to purify terminase complexes from cells in-
fected with recombinant viruses that encode deletions or
mutations of specific conserved amino acids within the terminase
subunits, allowing further elucidation of those domains that are es-
sential for terminase complex assembly and function in the context of
viral infection. The ability to purify endogenous terminase complexes
is novel for the field and represents a critical step toward establishing
an in vitro HSV-1 cleavage and packaging system.
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